Personal tools
Helpful Links
Information

Immuno-Biological Laboratories (4570)

Jump to: navigation, search


Company Profile

(As of March 2009)

Company Name Immuno-Biological Laboratories
Co., Ltd.
Head Office 5-1 Aramachi Takasaki-shi Gunma 370-0831
Phone 81-27-310-8040 Listed on  Hercules  
Established September 9, 1982 Exchange Listing  March 2, 2007  
Homepage http://www.ibl-japan.co.jp/eng/index.htm IR Web http://www.ibl-japan.co.jp/eng/ir.htm
IR Contact   IR Phone    
    IR Mail do-investor-relations@ibl-japan.co.jp
Consolidated
Segment Data
(Sales, OP)
Reagents related business for R&D(54.36%、%) Top Shareholders Tsutomu Seito 18.08%
Laboratory animal related business
(34.69%, -%)
  Iwai Chemicals Co. 3.24%
  Drug discovery related business
(10.58%, -%)
  Nomura Research & Advisory 2.99%
  Other(0.38%, -%)   Nobuyuki Matsumura 2.69%
Directors Tsutomu Seito, President   Nikko Ant Factory Co., Ltd. 2.43%
  Masahiro Maeda, Director   Nichirei Bio Science 2.43%
  Masato Nakagawa, Director   Eiken Chemical Co., Ltd. 2.02%
  Masanari Kawaminami, Director   Kiyoshi Umemura 1.97%
  Kiyoshi Imaizumi, Standing Auditor   C-Investment 1.94%
  Yasuyoshi Ishihara, Auditor   Jafco Co., Ltd. 1.81%
  Hiroyuki Watanabe, Auditor Shares Outstanding 616 thousand shares (As of March 2009)
  7 others Shareholders Capital 1,572 million yen (As of March 2009)
  (As of March 2009) Subsidiaries  
Employees (Cons) n.a.  Main Banks The Gunma Bank, Ltd., Mizuho Bank, Ltd.,
The Towa Bank, Ltd.
Employees (Par) 68 Credit Ratings n.a.
Average Age (Par) 39 Auditors Ernst & Young ShinNihon LLC
Annual Salary (Par)      
       

[edit] Financial Summary

[edit] Executive Summary

[edit] History

[edit] Business

[edit] Main Business and Product

[edit] Main Facilities

[edit] Business Model

[edit] Profitability Snapshot, Financial Ratios

[edit] SW Analysis

[edit] Market and Value Chain

[edit] Market Overview

[edit] Geography of Operations

[edit] Clients

[edit] Suppliers

[edit] Barriers to Entry

[edit] Competitors

[edit] Substitutes

[edit] Growth and Cycle

[edit] Strategy

[edit] Group Companies

[edit] Group Strategy

[edit] News and Topics

[edit] Company News and Topics

[edit] Industry News and Topics

[edit] Past Earnings Discussion

[edit] Actual Results

[edit] Statement of Income

[edit] Past Forecasts and Actual Results

[edit] Future Earnings Discussion

[edit] Company Forecast for the Current Fiscal Year

[edit] Quarterly Performance

[edit] Monthly Performance Data

[edit] Next Fiscal Year Forecast

[edit] Future Outlook

[edit] Balance Sheet Analysis

[edit] Cash Flows

[edit] Stock

[edit] Shareholders

[edit] Number of Shares

[edit] Shareholder Returns

[edit] Exchange Listing

[edit] Management

[edit] Employees

[edit] Investor Relations